中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
17期
90-91,111
,共3页
高血脂%糖尿病视网膜病变%黄斑水肿%药物治疗
高血脂%糖尿病視網膜病變%黃斑水腫%藥物治療
고혈지%당뇨병시망막병변%황반수종%약물치료
Hyperlipidemia%Diabetic retinopathy%Macular edema%Drug therapy
目的探究普罗布考治疗高血脂非增生型糖尿病视网膜病变的临床疗效。方法对我院2011年9月~2012年9月临床确诊为高血脂非增生型糖尿病视网膜病变的患者50例100只眼,进行治疗。把患者进行随机平均分组,分为治疗组和对照组,每组25例患者50只眼。对两组患者进行同样的饮食、运动指导,并服用降糖药或者注射胰岛素,来控制血糖、血压,在此基础上对治疗组的患者使用普罗布考进行治疗,而对照组的患者只口服阿托伐他汀。对患者进行长期的治疗,观察其各项指标,进行分析。结果治疗组与对照组患者的微动脉瘤,相比治疗前都有减轻,总有效率分别为68.26%,34.45%,两组相比差异具有统计学意义(P<0.05)。治疗组与对照组在治疗后视力回升的总有效率分别为45.28%,42.36%,两组相比差异无统计学意义(P>0.05)。两组患者在治疗后黄斑水肿例数相对于治疗前有明显减少,差异具有统计学意义(P<0.05)。在治疗后,患者的甘油三酯、低密度脂蛋白胆固醇、总胆固醇都有明显下降,而且治疗组的8-羟基脱氧鸟苷相对与对照组更低。结论使用普罗布考治疗高血脂非增生型糖尿病视网膜病变能够降低患者的血脂、恢复患者的视力、还能有效的减轻黄斑水肿的情况,是值得临床应用推广的方法。
目的探究普囉佈攷治療高血脂非增生型糖尿病視網膜病變的臨床療效。方法對我院2011年9月~2012年9月臨床確診為高血脂非增生型糖尿病視網膜病變的患者50例100隻眼,進行治療。把患者進行隨機平均分組,分為治療組和對照組,每組25例患者50隻眼。對兩組患者進行同樣的飲食、運動指導,併服用降糖藥或者註射胰島素,來控製血糖、血壓,在此基礎上對治療組的患者使用普囉佈攷進行治療,而對照組的患者隻口服阿託伐他汀。對患者進行長期的治療,觀察其各項指標,進行分析。結果治療組與對照組患者的微動脈瘤,相比治療前都有減輕,總有效率分彆為68.26%,34.45%,兩組相比差異具有統計學意義(P<0.05)。治療組與對照組在治療後視力迴升的總有效率分彆為45.28%,42.36%,兩組相比差異無統計學意義(P>0.05)。兩組患者在治療後黃斑水腫例數相對于治療前有明顯減少,差異具有統計學意義(P<0.05)。在治療後,患者的甘油三酯、低密度脂蛋白膽固醇、總膽固醇都有明顯下降,而且治療組的8-羥基脫氧鳥苷相對與對照組更低。結論使用普囉佈攷治療高血脂非增生型糖尿病視網膜病變能夠降低患者的血脂、恢複患者的視力、還能有效的減輕黃斑水腫的情況,是值得臨床應用推廣的方法。
목적탐구보라포고치료고혈지비증생형당뇨병시망막병변적림상료효。방법대아원2011년9월~2012년9월림상학진위고혈지비증생형당뇨병시망막병변적환자50례100지안,진행치료。파환자진행수궤평균분조,분위치료조화대조조,매조25례환자50지안。대량조환자진행동양적음식、운동지도,병복용강당약혹자주사이도소,래공제혈당、혈압,재차기출상대치료조적환자사용보라포고진행치료,이대조조적환자지구복아탁벌타정。대환자진행장기적치료,관찰기각항지표,진행분석。결과치료조여대조조환자적미동맥류,상비치료전도유감경,총유효솔분별위68.26%,34.45%,량조상비차이구유통계학의의(P<0.05)。치료조여대조조재치료후시력회승적총유효솔분별위45.28%,42.36%,량조상비차이무통계학의의(P>0.05)。량조환자재치료후황반수종례수상대우치료전유명현감소,차이구유통계학의의(P<0.05)。재치료후,환자적감유삼지、저밀도지단백담고순、총담고순도유명현하강,이차치료조적8-간기탈양조감상대여대조조경저。결론사용보라포고치료고혈지비증생형당뇨병시망막병변능구강저환자적혈지、회복환자적시력、환능유효적감경황반수종적정황,시치득림상응용추엄적방법。
Objective To explore the clinical curative effect of probucolin in the treatment of hyperlipemia nonproliferating diabetic retinopathy(DR). Methods 100 eyes of 50 patients clinical diagnosed hyperlipemia nonproliferating diabetic retinopathy(DR) in our hospital from September 2011 to September 2012 were treated. The patients were randomly and equally divided into two groups, namely the treatment group and the control group, each group had 50 eyes of 25 patients.The patients of two groups were given the same diet and exercise guidance,and taken hypoglycemic drugs or injected insulin to control the blood sugar and blood pressure.On the basis,the patients in the treatment group were treated with probucol,while the patients in the control group only received atorvastatin.The patients were given long-term treatment,and the various indicators were observed and analyzed. Results Compared with before treatment,the microaneurysm of patients in the treatment group and the control group reduced, and the total effective rate was 68.26%,34.45%respectively,the difference was statistically significant(P<0.05).The total effective rate of vision upswing after treatment in the treatment group and the control group was 45.28%,42.36%respectively,and the difference was not statistically significant(P > 0.05).Compared with before treatment,the number of macular edema after treatment in two groups reduced obviously, and the difference was statistically significant(P<0.05).The triglyceride, low density lipoprotein cholesterol and total cholesterol of patients after treatment decreased significantly, and the 8-hydroxydeoxyguanosine of the treatment group was lower than that of the control group. Conclusion Probucolin for hyperlipemia nonproliferating diabetic retinopathy(DR) can reduce blood lipid,recover vision,effectively reduce macular edema,and is worthy of clinical promotion and application.